Back to search results

Tissue Collection for Various Gastrointestinal Cancers

This study is collecting and storing tissue and blood samples from people with different types of cancer, including stomach (gastric), esophageal (foodpipe), pancreas, liver, and colorectal cancers, among others. Researchers want to gather normal and cancerous tissue, as well as blood, to create a database. This database will help them understand these cancers better and support future research. You may be able to join if you have been diagnosed with one of the listed cancers and are undergoing surgery or a biopsy. The main goal is to collect and store these samples and create the database within one year.

Study design
This is an observational study aiming to enroll 1000 participants. It is designed to collect and store tissue and blood samples.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary goals of collecting samples and creating a database are measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01416714

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Recruiting
Not specifiedAll AgesObservational
University of Chicago
~1,000 participants
Updated 2025-10-01 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Collect and store blood samples
Measured over 1 year
+1 more outcome measured

Conditions

Gastric Cancers

Explore related trials

Anal CarcinomaBiliary CancerColorectal CarcinomaEsophageal CarcinomaGastric CarcinomaGastrointestinal Stromal TumorMalignant Liver NeoplasmMalignant Pancreatic NeoplasmNeuroendocrine TumorPeritoneal Malignant Mesothelioma

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Daniel Catenacci, MD · PRINCIPAL_INVESTIGATOR · University of Chicago

Who to contact

Daniel Catenacci, MD
[email protected]
773-702-7596
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

any patient diagnosed with Gastric (stomach) Cancer, Esophageal (foodpipe) Cancer, Pancreas Cancer, Liver Cancer, Biliary (gallbladder) Cancer, Gastrointestinal Stromal Tumor, Peritoneal Mesothelioma (cancer in the lining of the abdomen), Neuroendocrine (of or relating to the cells that release a hormone into the blood in response to a neural stimulus) Tumor, Anal Cancer or Colorectal Cancer cancer that requires you to undergo a surgical or diagnostic procedure.

What this trial measures

  • Collect and store blood samples1 year

    To collect and store blood samples from patients with gastric cancer, GIST, esophageal cancer, pancreas cancer, hepatocellular cancer, biliary cancer, neuroendocrine, peritoneal mesothelioma, anal cancer and colorectal cancer.

  • create a database for the collected tissue1 year

    To create a database for the collected tissue and allow access to relevant clinical information for current and future protocols.